Skip to content
healthcare.dev

Abiraterone Acetate

NDC 0378-6920, abiraterone acetate, tablet, from Mylan Pharmaceuticals Inc..

Product NDC
0378-6920
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208446
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0378-6920 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABIRATERONE ACETATE250 mg/1

Pharmacologic classes

Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]

Package NDCNDC-11Package
0378-6920-7800378692078120 TABLET in 1 BOTTLE, PLASTIC (0378-6920-78)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fe02db79-fa04-441f-b514-70bd74af6624
  • NADAC price for package 00378692078

    GET /v1/drugs/nadac/00378692078

Use it

Look up 0378-6920 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0378-6920 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0378-6920. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.